interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Benzoyl Peroxide

Generic competition · all medicines · read 12 November 2026

Is there a generic of Benzoyl Peroxide, and who makes it?

Benzoyl Peroxide appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Benzoyl Peroxide1 dosage-form group in the Orange Book
0generic makers listed
  1. Benzoyl Peroxide appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Cream, Topical

Brand listed, no generic listed as marketed

Brand listed as marketed: Epsolay. No generic is listed as marketed.

20202025203020352040204501brand 2022data datePatent 12350382 listed to expire 3 February 2028Patent 12156946 listed to expire 3 February 2028Patent 9868103 listed to expire 8 August 2028Patent 9687465 listed to expire 27 November 2032Patent 10945987 listed to expire 19 February 2040Patent 11877997 listed to expire 19 February 2040Patent 10933046 listed to expire 19 February 2040Patent 11541026 listed to expire 19 February 2040Patent 11986456 listed to expire 19 February 2040Patent 11865100 listed to expire 19 February 2040Patent 11426378 listed to expire 18 August 2040Patent 12295935 listed to expire 27 December 2040Patent 11628155 listed to expire 27 December 2040Patent 12257348 listed to expire 23 May 2041
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 3 February 2028Patent 12350382 drug product
  • 3 February 2028Patent 12156946 drug product
  • 8 August 2028Patent 9868103 drug product
  • 27 November 2032Patent 9687465 drug product
  • 19 February 2040Patent 10945987
  • 19 February 2040Patent 11877997
  • 19 February 2040Patent 10933046 drug product
  • 19 February 2040Patent 11541026

6 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.